Leef Brands (LEEEF) Other Non-Current Liabilities (2023 - 2026)
Leef Brands (LEEEF) posted Other Non-Current Liabilities of $11.5 million for Q1 2026, up 29.47% sequentially from $8.9 million in Q4 2025.
Leef Brands (LEEEF) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends
Leef Brands has reported Other Non-Current Liabilities for 4 years, with the latest figure at $11.5 million in Q1 2026.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $11.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.5 million (changed N/A YoY) and the FY2025 annual result came in at $8.9 million, down 1.27% from the prior year.
- Other Non-Current Liabilities improved to $11.5 million in Q1 2026 per LEEEF's latest filing, from $8.9 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $11.5 million in Q1 2026 and troughed at $1.1 million in Q4 2023.
- A 4-year average of $7.6 million and a median of $9.0 million in 2024 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities surged 723.15% in 2024, then decreased 1.27% in 2025.
- Over 4 years, Other Non-Current Liabilities stood at $1.1 million in 2023, then jumped by 723.15% to $9.0 million in 2024, then decreased by 1.27% to $8.9 million in 2025, then rose by 29.47% to $11.5 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $11.5 million, $8.9 million, and $9.0 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Leef Brands | 59.45 Mn | 54.50 Mn | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.53 Mn |
| Mar 31, 2026 | 11.51 Mn |
| Dec 31, 2025 | 8.89 Mn |
| Dec 31, 2024 | 9.01 Mn |
| Dec 31, 2023 | 1.09 Mn |